Owkin

Owkin, founded in 2016 by Thomas Clozel, M.D., a clinical research doctor, and Gilles Wainrib, Ph.D., a pioneer in machine learning for biology, is headquartered in Paris, France. The company specializes in utilizing artificial intelligence to advance drug discovery and development, with a particular focus on oncology. By integrating multimodal patient data—including biomedical images, genomics, and clinical information—Owkin’s platform uncovers complex biomarkers and disease mechanisms, facilitating the development of targeted therapies and enhancing clinical trial design.

Owkin has attracted significant investment from a diverse group of investors. Notable backers include Sanofi, Bristol-Myers Squibb, GV (formerly Google Ventures), Bpifrance, Cathay Innovation, and Mubadala. In November 2021, Sanofi invested $180 million in Owkin, elevating the company’s valuation to $1 billion.

What sets Owkin apart is its pioneering use of federated learning—a privacy-preserving AI framework that enables the training of machine learning models across multiple institutions without centralizing data. This approach allows Owkin to collaborate with a network of leading academic and medical institutions, accessing diverse datasets while maintaining patient privacy. By leveraging this extensive data ecosystem, Owkin enhances the accuracy and generalizability of its predictive models, thereby accelerating the identification of novel therapeutic targets and optimizing clinical trial outcomes.

In the artificial intelligence landscape, Owkin operates within the category of AI-driven precision medicine. The company applies machine learning algorithms to complex biological and clinical datasets, aiming to transform drug discovery and development processes. By focusing on understanding disease biology through AI, Owkin contributes to the advancement of personalized healthcare solutions.

For more information, please visit owkin.com.

To claim this startup page, go to the Contact page and send us a message with your full name, startup name, job title, and startup email address. We will review your request and get back to you. Once verified, you can update your startup information.